Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia | Zendy

ChihJung Chen | Zendy; YhuChering Huang | Zendy; Cheng-Hsu Chiu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia

Author(s) -

ChihJung Chen,

YhuChering Huang,

Cheng-Hsu Chiu

Publication year - 2015

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkv225

Subject(s) - daptomycin , glycopeptide , vancomycin , medicine , methicillin resistant staphylococcus aureus , staphylococcal infections , staphylococcus aureus , microbiology and biotechnology , bacteremia , drug resistance , antibacterial agent , antibiotics , biology , bacteria , genetics

The development of non-susceptibility to glycopeptides and daptomycin in MRSA during persistent bacteraemia has become a significant therapeutic challenge. However, the in vivo evolution and mechanism of the dual resistance have remained incompletely understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research